Remote Maintenance Cardiac Rehabilitation
MAINTAIN
2 other identifiers
interventional
30
1 country
1
Brief Summary
The investigators would like to test the feasibility of a remotely prescribed and monitored exercise program in people with coronary heart disease, using a wearable activity device and text message support, compared to usual care after completing cardiac rehabilitation. One group will use a Polar Ignite watch to guide them through exercise sessions at home and will receive text message feedback. The other group will be asked to continue their routine as usual. Assessments of both groups will happen after the completion of cardiac rehabilitation and at three follow-up time points of three, six, and twelve months. The aim of these treatments is to see if the investigators can help people to maintain their exercise adherence and coronary heart disease risk factor management after completing cardiac rehabilitation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 16, 2021
CompletedFirst Posted
Study publicly available on registry
March 23, 2022
CompletedStudy Start
First participant enrolled
March 28, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 15, 2024
CompletedAugust 20, 2024
August 1, 2024
1.9 years
December 16, 2021
August 19, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (10)
Intervention feasibility assessed via recruitment rate.
The investigators will complete enrolment logs to record the number of people who enrol in the study.
Will be evaluated after the 12-month follow up assessment
Intervention feasibility assessed via number of screened patients.
The investigators will complete screening logs to record the number of eligible participants.
Will be evaluated after the 12-month follow up assessment
Intervention feasibility assessed via number of patients randomised.
The investigators will complete randomisation logs to record the number of participants randomised to both groups.
Will be evaluated after the 12-month follow up assessment
Intervention feasibility assessed via number of patients retained in the study.
The investigators will assess the number of participants who withdraw or stay within the study.
Will be evaluated after the 12-month follow up assessment
Adherence to the prescribed exercise sessions.
The investigators will collect exercise session data recorded by the Polar Ignite watches worn by the participants in the intervention arm. The percentage of prescribed exercise sessions completed will be assessed.
Will be evaluated after the 12-month follow up assessment.
Adherence to the prescribed exercise sessions' intensity.
The investigators will collect exercise session data recorded by the Polar Ignite watches worn by the participants in the intervention arm. The percentage of exercise time completed at the correct intensity will be assessed.
Will be evaluated after the 12-month follow up assessment.
Adherence to the prescribed exercise sessions' duration.
The investigators will collect exercise session data recorded by the Polar Ignite watches worn by the participants in the intervention arm. The percentage of exercise time completed at the correct duration will be assessed.
Will be evaluated after the 12-month follow up assessment.
Trial acceptability of the interventions and trial procedures via participant interviews
Qualitative semi-structured interviews carried out with control and intervention participants as well as interviews with participants who withdraw from the study.
Interviews at 3 months
Trial acceptability of the interventions and trial procedures via participant interviews
Qualitative semi-structured interviews carried out with control and intervention participants as well as interviews with participants who withdraw from the study.
Interviews at 6 months
Trial acceptability of the interventions and trial procedures via participant interviews
Qualitative semi-structured interviews carried out with control and intervention participants as well as interviews with participants who withdraw from the study.
Interviews at 12 months
Secondary Outcomes (13)
Exercise capacity determined using an Incremental Shuttle Walk Test (ISWT).
Baseline, 3-, 6- and 12 month follow up post randomisation
Physical activity and sedentary behaviour
The Actigraph will be worn during the baseline assessment and the 3-, 6, and 12-month follow up post randomisation.
Exercise frequency and intensity
It will be completed monthly from baseline to the 12-month follow up period to assess change over time.
Cardiovascular disease risk using the Second Manifestations of Arterial disease (SMART) risk score
Measured at baseline, 3-, 6- and 12-month follow up
Cardiac specific quality of life using the MacNew Quality of Life Questionnaire
Baseline, 3-, 6-, and 12-months post randomisation.
- +8 more secondary outcomes
Study Arms (2)
Home-based Watch Intervention
EXPERIMENTALThe home-based watch group will receive an exercise consultation with an exercise physiologist followed by check-in sessions at 1-month, 3-months, 6-months, and 12-months post-randomisation to set and review exercise and physical activity goals. They will wear a Polar Ignite wearable activity monitor which will help to monitor and guide their exercise sessions. Text-message feedback will be provided by an exercise physiologist based on information gathered from exercise sessions recorded on the watch by the participant.
Best Practice Usual Care Control
NO INTERVENTIONNo intervention will be administered. Best practice usual care and activity.
Interventions
A wearable activity monitor capable of monitoring outcomes relating to physical activity sedentary time, heart rate, and sleep quality. The watch synchronises to a corresponding mobile app called Polar Flow- Sync and Analyze or to the Polar FlowSync data transfer software on a computer.
Eligibility Criteria
You may qualify if:
- Diagnosed coronary heart disease.
- Completed community cardiac rehabilitation.
- Clinically stable (symptoms and medication).
- Men and women aged over 18.
- Access to smartphone with Bluetooth capacity or a computer/laptop.
- Able to provide informed consent.
You may not qualify if:
- Absolute contraindications to exercise as per international clinical guidelines.
- Any serious mental health/cognitive issue that will prevent engagement with study procedures or increase the risk of exercise complications.
- Diagnosed atrial fibrillation or other arrhythmia preventing accurate heart rate measurement.
- Allergy to watch materials.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Atrium Health Limited
Coventry, West Midlands, CV1 3LN, United Kingdom
Related Publications (1)
Denton F, Waddell A, Kite C, Hesketh K, Atkinson L, Cocks M, Jones H, Randeva H, Davenport N, Powell R, Clark C, Kyrou I, Harwood AE, McGregor G. Remote maintenance cardiac rehabilitation (MAINTAIN): A protocol for a randomised feasibility study. Digit Health. 2023 Feb 15;9:20552076231152176. doi: 10.1177/20552076231152176. eCollection 2023 Jan-Dec.
PMID: 36818155DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gordon McGregor, PhD
Coventry University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The researcher carrying out the follow up assessments will be blinded to the arm participants have been randomised to.
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief Investigator
Study Record Dates
First Submitted
December 16, 2021
First Posted
March 23, 2022
Study Start
March 28, 2022
Primary Completion
February 15, 2024
Study Completion
February 15, 2024
Last Updated
August 20, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share